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Abstract
Introduction: Prostate needle-biopsies are among the most common specimens in routine
histopathological practice; in 15% colorectal tissue is also present. Rectal pathology is described to
be found in 17% of this coincidentally obtained material.
Case presentation: We present a case in which colorectal carcinoid was found in the rectal
mucosa obtained via transrectal prostate biopsies in a screening program for prostate cancer in a
71-year old Caucasian male. To the best of our knowledge, this was the first time that such a
coincidental finding was discovered. Besides a colonoscopy with polypectomy, this coincidental
detection remained without any further clinical consequences for this patient until today.
Conclusion: As there is a considerable chance that abnormalities are found in the rectal tissue of
prostate biopsies, it is advisable for all pathologists to include this tissue in the histology evaluation
and look for potential irregularities in this simultaneously collected material.
Introduction
Prostate needle-biopsies are among the most common
specimens in routine histopathological practice following
cutaneous and gastro-intestinal biopsies. Sporadically,
non-prostatic pathology is encountered in needle-biop-
sies representing either generalised disease such as vascu-
litis or tuberculosis, or loco-regional aberrations i.e.
extension of bladder or colorectal carcinoma. Here, we
report on a case of incidentally finding colorectal carci-
noid identified at prostate biopsies. To the best of our
knowledge, this has never been described in the English
literature before.
Case presentation
The 71-year-old Caucasian male subject without any
comorbidity participated in the Dutch section of the Euro-
pean Randomized Study of Screening for Prostate Cancer
(ERSPC). This study has been ongoing for almost 15 years
in 8 European countries and aims to explore the feasibility
of population-based screening for prostate cancer [1].
Almost 270.000 men have been randomized to the
screening or control group. Prostate biopsy indications
have changed during the course of the study, but include
abnormal digital rectal examination (DRE) and/or tran-
srectal ultrasound (TRUS) findings, and/or elevated levels
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or PCA3 (Prostate Cancer Gene 3) in the urine [2].
In October 2007 our patient was screened using a meas-
urement of the PSA serum level. His PSA was with 1.2 ng/
ml below the biopsy-threshold of 3.0 ng/ml. However, as
this man had also consented in participating in the PCA3
side study, his urinary sample (collected after DRE) was
subjected to PCA3 analysis, which resulted in a score of
13. Since a threshold of PCA3 > 10 was used as a biopsy
indication, this prompted DRE, TRUS, and lateralised sex-
tant TRUS-guided prostate biopsies [3].
No abnormalities were found during DRE and TRUS.
Prostate volume measured by planimetric calculation was
30.9 cc. Histopathologic evaluation revealed no prostate
cancer in the 6 biopsy-cores. However, in 2 of the 3 nee-
dle-biopsies that also contained rectal mucosa (number
IV and V; taken from the left lateral side of the basis and
middle of the prostate), a carcinoid was coincidentally
found in the rectal mucosa. Small nests, glands and
strands consisting of epithelial cells were present within
the rectal muscularis mucosae (Figure 1). These epithelial
cells were characterised by an eosinophilic, finely granular
cytoplasm, a round nucleus and inconspicuous nucleolus.
No significant atypia, mitotic activity or necrosis was
encountered. Additional immunohistochemical stainings
showed strong expression of chromogranin and synapto-
physin compatible with a carcinoid/low-grade neuroen-
docrine tumour. Molecular investigation eliminated the
option of mixing of specimens.
Our patient was informed about the benign outcome of
his prostate biopsies and the remarkable finding in the
rectal mucosa by the principal investigator of the ERSPC
and he was advised to make an appointment with the gas-
troenterologist. Besides constipation, no complaints of
the gastroenterologic tract or lab changes were found. A
colonoscopy was performed, during which two polyps
were seen, the first at 2 cm from the anus and the second
at 90 cm. The carcinoid was not detected during colonos-
copy, probably because it was located in the submucosa.
Both polyps were removed endoscopically and sent in for
pathologic examination. The lesion in the rectum was a
tubulovillous adenoma with low-grade dysplasia. The sec-
ond was a hyperplastic polyp without any adenomatous
changes. Because of the first finding, the patient was
advised to undergo a control colonoscopy after 6 years.
Until today the incidental finding of carcinoid did not
have any clinical consequences for this patient.
Discussion
Carcinoid is a slow-growing but often malignant type of
neuroendocrine tumour, which can arise from the entero-
chromaffin cells throughout different organs of the diges-
tive and respiratory tract, and has the ability to secrete
different endocrine products. In 10–20% of cases there are
multiple localisations. The appendix has previously been
described as the most common localisation, followed by
the ileum, rectum, and stomach, but recently a marked
increases in gastric and rectal carcinoids and a concomi-
tant decrease in appendiceal carcinoid incidence has been
observed. Patients with metastatic carcinoid, especially
those with metastases in the liver, can show signs of the
carcinoid syndrome. This is due to the production of sero-
tonin, which is released into the systemic circulation,
which leads to symptoms of cutaneous flushing, diar-
rhoea, bronchoconstriction and right-sided cardiac valve
disease. The incidence is approximately 10–20 new clini-
cal cases per million per year. Often these tumours how-
ever remain subclinical and are found coincidentally in
resection specimens or at obduction (in 1%) [4,5].
In this case-report, prostate biopsies were the basis of the
surprising finding of carcinoid. As TRUS-guided prostate
biopsies perforate the wall of the rectum, biopsy core
specimens may also contain a small piece of colorectal tis-
sue. This part could potentially harbour pathology or
could incur artefacts that cause diagnostic difficulty. One
should especially be aware that prostate adenocarcinoma,
particularly of ductal-type cancer might simulate rectal
adenoma [6]. A tubulo-villous growth pattern with elon-
gated nuclei and frequent detachment of pre-existent
prostate tissue should prompt close pathologic examina-
tion eventually sustained with immunohistochemistry.
A recent retrospective article found rectal mucosa in 114
out of 782 (14.6%) reviewed prostate biopsy cores. Mate-
rial from as much as 19 of these 114 (16.7%) showed rel-
evant rectal pathology, consisting of a hyperplastic polyp
in 1, changes consistent with ulcerative proctitis in 8, focal
active proctitis in 7, and granulomas in 3 [7]. Incidental
findings due to other investigations of the prostate besides
biopsies, such as the finding of rectal carcinoma during
TRUS, have also been described [8].
The patient in our report did not have any complaints of
the carcinoid, neither were any lab changes found.
Although having had the extra burden of the diagnosis
carcinoid and a colonoscopy as the result of the screening
procedure for prostate cancer, no further clinical conse-
quences were related to this rare finding.
Conclusion
We report on a case of the finding of colorectal carcinoid
in the rectal mucosa obtained via prostate biopsies in a
screening program for prostate cancer. Although this spe-
cific finding is rare, concomitant colorectal pathology in
coincidentally obtained tissue at prostate biopsy is not
uncommon. Histology evaluation of prostatic needle-Page 2 of 4
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Rectal mucosa (haematoxylin-eosin, ×40) with a carcinoid within the muscularis mucosae, characterised by a proliferation of n sts, glands nd strands of on-atypical epithelial cells (A), w ch d onstr te expression of synaptophysin (B)Figure 1
Rectal mucosa (haematoxylin-eosin, ×40) with a carcinoid within the muscularis mucosae, characterised by a 
proliferation of nests, glands and strands of non-atypical epithelial cells (A), which demonstrate expression of 
synaptophysin (B).
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biopsies should therefore include examination of the
adjacent colorectal wall.
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